Service de Gériatrie Aiguë - CHU de Strasbourg - France
Strasbourg, 67091, France
Location status: Recruiting
NCT Number: NCT07303166
The aging population is associated with an increase in the number of elderly people as well as in chronic diseases, particularly osteoporosis and its fracture consequences, which lead to a decline in quality of life and life expectancy. Improved management of osteoporosis would help reduce the morbidity and mortality associated with this disease.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Strasbourg, 67091, France
Location status: Recruiting
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Up to 12 months
Identify the factors promoting and hindering the use of a practical guide on the management of osteoporosis
Interested in participating?
Request InfoUniversity Hospital, Strasbourg, France
Other
Qualitative Study Exploring the Determinants Involved in the Management of Osteoporosis in Frail Elderly People by Doctors in Alsace Who Had Access to a Practical Guide on Osteoporosis
Acronym: QualiFichOs
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06118905
Bone Diseases, Bone Diseases, Metabolic
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT06041789
Bone Diseases, Bone Diseases, Metabolic
Durham, North Carolina, United States
View Trial DetailsNCT07824102
Adrenal Gland Disease, Adrenal Gland Diseases
Herlev, Denmark
View Trial DetailsNCT07367776
Bone Diseases, Bone Diseases, Metabolic
Gävle, Sweden
View Trial Details